February 21, 2007 – InSightec’s ExAblate 2000, a Magnetic Resonance Imaging (MRI) focused ultrasound device that treats uterine fibroid tumors, is now allowing most patients to find relief within three months of treatment and to return to work within days.
The ExAblate 2000 uses a combination of ultrasound waves and MRIs to image, treat and ablate soft tissue. Treatment typically takes about three or four hours.
May 7, 2026 — Openwater, an open-source medical technology company has announced a collaboration with the Sharma Lab, a ...
May 07, 2026 
April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...
April 28, 2026 
April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...
April 23, 2026 
April 20, 2026 — Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in ...
April 23, 2026 
April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...
April 09, 2026 
March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...
March 31, 2026 
March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...
March 30, 2026 
March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...
March 23, 2026 
March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...
March 17, 2026 
March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...
March 13, 2026 